[1. Brasse-Lagnel C. et al.: Glutamine stimulates argininosuccinate synthetase gene expression through cytosolic O-glycosylation of Sp1 in Caco-2 cells. J Biol Chem., 278, 52504, 2003.10.1074/jbc.M30675220014570901]Search in Google Scholar
[2. Castillo J., Rodriguez I.: Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis., 17 Suppl 1, 7, 2004.10.1159/00007479114694276]Search in Google Scholar
[3. Harston, George W J et al.: The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity. J Cereb Blood Flow Metab., 30, 1804, 2010.]Search in Google Scholar
[4. Horecka A. et al.: Actylise treatment does not influence nitric oxide metabolites serum level. Pharmacol Rep, 2016.10.1016/j.pharep.2015.12.01026971035]Search in Google Scholar
[5. Huang Y.F., Wang Y., Watford M.: Glutamine directly downregulates glutamine synthetase protein levels in mouse C2C12 skeletal muscle myotubes. J Nutr., 137, 1357, 2007.]Search in Google Scholar
[6. Karna E., Szoka L., Palka J.A.: Captopril-dependent inhibition of collagen biosynthesis in cultured fibroblasts. Pharmazie., 65, 614, 2010.]Search in Google Scholar
[7. Kimberly W.T. et al.: Metabolite profiling identifies a branched chain amino acid signature in acute cardioembolic stroke. Stroke., 44, 1389, 2013.10.1161/STROKEAHA.111.000397381608923520238]Search in Google Scholar
[8. Kuklina E.V. et al.: Epidemiology and prevention of stroke: a worldwide perspective. Expert Rev Neurother., 12, 199, 2012.10.1586/ern.11.99447858922288675]Search in Google Scholar
[9. Kurzepa J. et al.: Thrombolytic treatment decreases glutamate/GABA ratio in serum during acute ischaemic stroke: a pilot study. Neurol Res., 37, 934, 2015.10.1179/1743132815Y.000000004926005019]Search in Google Scholar
[10. Miao Y., Liao J.K.: Potential serum biomarkers in the pathophysiological processes of stroke. Expert Rev Neurother., 14, 173, 2014.]Search in Google Scholar
[11. Nagata C. et al.: Dietary intakes of glutamic Acid and glycine are associated with stroke mortality in Japanese adults. J Nutr., 145, 720, 2015.10.3945/jn.114.20129325833775]Search in Google Scholar
[12. Newsholme P. et al.: New insights into amino acid metabolism, beta-cell function and diabetes. Clin Sci (Lond)., 108, 185, 2005.10.1042/CS2004029015544573]Search in Google Scholar
[13. Phang J.M. et al.: Proline metabolism and cancer: emerging links to glutamine and collagen. Curr Opin Clin Nutr Metab Care., 18, 71, 2015.10.1097/MCO.0000000000000121425575925474014]Search in Google Scholar
[14. Raman K., Pare G.: Of stroke and biomarkers: the elusive quest for a clinical biomarker panel. Clin Biochem., 46, 705, 2013.]Search in Google Scholar
[15. Salemi G. et al.: Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke. Neurol Sci., 30, 361, 2009.]Search in Google Scholar
[16. Skovierova H. et al.: Effect of homocysteine on survival of human glial cells. Physiol Res, 2015.10.33549/physiolres.93289725804098]Search in Google Scholar
[17. Staszewski J. et al.: Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. J Stroke Cerebrovasc Dis., 20, 150, 2011.10.1016/j.jstrokecerebrovasdis.2009.11.01320621520]Search in Google Scholar
[18. Szpetnar M., Pasternak K., Boguszewska A.: Branched chain amino acids (BCAAs) in heart diseases (ischaemic heart disease and myocardial infarction). Ann Univ Mariae Curie Sklodowska Med., 59, 91, 2004.]Search in Google Scholar
[19. Takemoto Y.: Intracisternally injected L-proline activates hypothalamic supraoptic, but not paraventricular, vasopressin-expressing neurons in conscious rats. J Amino Acids., 2011, 230613, 2011.10.4061/2011/230613326803422312458]Search in Google Scholar
[20. Tom A., Nair K.S.: Assessment of branched-chain amino Acid status and potential for biomarkers. J Nutr., 136, 324S-30S, 2006.10.1093/jn/136.1.324S16365107]Search in Google Scholar
[21. Watford M.: Lowered concentrations of branched-chain amino acids result in impaired growth and neurological problems: insights from a branched-chain alpha-keto acid dehydrogenase complex kinase-deficient mouse model. Nutr Rev., 65, 167, 2007.10.1301/nr.2007.apr.167-172]Search in Google Scholar
[22. Wong, Peter T H et al.: High plasma cyst(e)ine level may indicate poor clinical outcome in patients with acute stroke: possible involvement of hydrogen sulfide. J Neuropathol Exp Neurol., 65, 109, 2006.]Search in Google Scholar
[23. Wu G.: Amino acids: metabolism, functions, and nutrition. Amino Acids., 37, 1, 2009.]Search in Google Scholar
[24. Wu G. et al.: Arginine metabolism and nutrition in growth, health and disease. Amino Acids., 37, 153, 2009.10.1007/s00726-008-0210-y267711619030957]Search in Google Scholar